« Previous
Next »
Survey of Ophthalmology
Volume 54, Issue 6
, Pages
686-696
, November 2009
Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
To access this article, please choose from the options below
Dr Tseng has obtained a patent for the method of preparation and clinical uses of amniotic membrane and has licensed the right to Bio-Tissue, which procures, processes, and distributes preserved amniotic membrane for clinical and research uses. The other authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. Ahmad Kheirkhah is a recipient of Joseph Swiger and Eye Foundation of America Fellowship from Ocular Surface Research and Education Foundation, Miami, FL. Dr. Lingyi Liang received the Exchange Scholarship Grant for PhD candidates from the Scholarship Council of China.
PII: S0039-6257(09)00119-2
doi: 10.1016/j.survophthal.2009.03.004
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Survey of Ophthalmology
Volume 54, Issue 6
, Pages
686-696
, November 2009
